Effects of the traditional Mediterranean diet on adiponectin and leptin concentrations in men and premenopausal women: Do sex differences exist?

European Journal of Clinical Nutrition

Volumn 68, Issue 5, 2014, Pages 561-566

  Bedard A ^a,b   Tchernof, A ^a,b,c   Lamarche, B ^a,b   Corneau, L ^a   Dodin, S ^a,b   Lemieux, S ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; FEMALE; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; INSULIN SENSITIVITY; MALE; MEDITERRANEAN DIET; NORMAL HUMAN; PREMENOPAUSE; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; TREATMENT RESPONSE; WAIST CIRCUMFERENCE; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; HOMEOSTASIS; INSULIN RESISTANCE; INTERVENTION STUDY; MIDDLE AGED; RISK FACTOR; YOUNG ADULT;

ADIPONECTIN; ADULT; APOLIPOPROTEIN A-I; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET, MEDITERRANEAN; FEMALE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; INTERVENTION STUDIES; LEPTIN; MALE; MIDDLE AGED; PREMENOPAUSE; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84899902948     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2014.27     Document Type: Article

References (36)

1. Turer AT, Scherer PE. Adiponectin: Mechanistic insights and clinical implications. Diabetologia 2012; 55: 2319-2326
2. Brooks NL, Moore KS, Clark RD, Perfetti MT, Trent CM, Combs TP. Do low levels of circulating adiponectin represent a biomarker or just another risk factor for the metabolic syndrome? Diabetes Obes Metab 2007; 9: 246-258
3. Zhang H, Mo X, Hao Y, Huang J, Lu X, Cao J et al. Adiponectin levels and risk of coronary heart disease: A meta-Analysis of prospective studies. Am J Med Sci 2013; 345: 455-461
4. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003; 361: 226-228
5. Söderberg S, Zimmet P, Tuomilehto J, Chitson P, Gareeboo H, Alberti KG et al. Leptin predicts the development of diabetes in Mauritian men, but not women: A population-based study. Int J Obes 2007; 31: 1126-1133
6. McNeely MJ, Boyko EJ, Weigle DS, Shofer JB, Chessler SD, Leonnetti DL et al. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care 1999; 22: 65-70
7. Bandaru P, Shankar A. Association between plasma leptin levels and diabetes mellitus. Metab Syndr Relat Disord 2011; 9: 19-23
8. Sattar N, Wannamethee G, Sarwar N, Chernova J, Lawlor DA, Kelly A et al. Leptin and coronary heart disease prospective study and systematic review. J Am Coll Cardiol 2009; 53: 167-175
9. Zhuo Q, Wang Z, Fu P, Piao J, Tian Y, Xu J et al. Comparison of adiponectin, leptin and, leptin to adiponectin ratio as diagnostic marker for metabolic syndrome in older adults of Chinese major cities. Diabetes Res Clin Pract 2009; 84: 27-33
10. Finucane FM, Luan J, Wareham NJ, Sharp SJ, O'Rahilly S, Balkau B et al. Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia 2009; 52: 2345-2349
11. Andreasson AN, Undén AL, Elofsson S, Brismar K. Leptin and adiponectin: Distribution and associations with cardiovascular risk factors in men and women of the general population. Am J Hum Biol 2012; 24: 595-601
12. Snijder MB, Heine RJ, Seidell JC, Bouter LM, Stehouwer CD, Nijpels G et al. Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women-The Hoorn study. Diabetes Care 2006; 29: 2498-2503
13. Samara A, Herbeth B, Aubert R, Berrahmoune H, Fumeron F, Siest G et al. Sex-dependent associations of leptin with metabolic syndrome-related variables: The Stanislas Study. Obesity 2010; 18: 196-201
14. Bédard A, Riverin M, Dodin S, Corneau L, Lemieux S. Sex differences in the impact of the Mediterranean diet on cardiovascular risk profile. Br J Nutr 2012; 108: 1428-1434
15. Minister of Health Canada Eating Well with Canada's Food Guide. 2007 http://www.hc-sc.gc.ca/fn-An/alt-formats/hpfb-dgpsa/pdf/food-guide-Aliment/view- eatwell-vue-bienmang-eng.pdf. Accessed 19 January 2014
16. Goulet J, Nadeau G, Lapointe A, Lamarche B, Lemieux S. Validity and reproducibility of an interviewer-Administered food frequency questionnairefor healthy French-Canadian men and women. Nutr J 2004; 3: 13
17. Hardie L, Trayhurn P, Abramovich D, Fowler P. Circulating leptin in women: A longitudinal study in the menstrual cycleand during pregnancy. Clin Endocrinol 1997; 47: 101-106
18. Escalante Pulido JM, Alpizar Salazar M. Changes in insulin sensitivity, secretion and glucose effectiveness during menstrual cycle. Arch Med Res 1999; 30: 19-22
19. Muesing RA, Forman MR, Graubard BI, Beecher GR, Lanza E, McAdam PA et al. Cyclic changes in lipoprotein and apolipoprotein levels during the menstrual cyclein healthy premenopausal women on a controlled diet. J Clin Endocrinol Metab 1996; 81: 3599-3603
20. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
21. Albers JJ, Warnick GR, Wiebe D, King P, Steiner P, Smith L et al. Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein. Clin Chem 1978; 24: 853-856
22. Richterich R, Dauwalder H. Determination of plasma glucose by hexokinase-glucose-6-phosphate dehydrogenase method. Schweiz Med Wochenschr 1971; 101: 615-618
23. Desbuquois B, Aurbach GD. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 1971; 33: 732-738
24. Rowland, M Tozer, TN. Clinical Pharmacokinetics: Concepts and Applications. Lea and Febiger: Philadelphia, PA, USA, 1980
25. Cederholm J, Wibell L. Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract 1990; 10: 167-175
26. The Airlie (VA) Consensus Conference: Standardization of Anthropometric easurements. Human Kinetics Publishers: Champaign, IL, USA, 1988
27. Richard C, Couture P, Desroches S, Charest A, Lamarche B. Effect of the Mediterranean diet with and without weight loss on cardiovascular risk factors in men with the metabolic syndrome. Nutr Metab Cardiovasc Dis 2011; 21: 628-635
28. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: A randomized trial. JAMA 2004; 292: 1440-1446
29. Fragopoulou E, Panagiotakos DB, Pitsavos C, Tampourlou M, Chrysohoou C, Nomikos T et al. The association between adherence to the Mediterranean diet and adiponectin levels among healthy adults: The ATTICA study. J Nutr Biochem 2010; 21: 285-289
30. Mantzoros CS, Williams CJ, Manson JE, Meigs JB, Hu FB. Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women. Am J Clin Nutr 2006; 84: 328-335
31. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women-A randomized trial. JAMA 2003; 289: 1799-1804
32. Esposito K, Di Palo C, Maiorino MI, Petrizzo M, Bellastella G, Siniscalchi I et al. Longterm effect of Mediterranean-style diet and calorie restriction on biomarkers of longevity and oxidative stress in overweight men. Cardiol Res Pract 2010; 2011: 293916
33. Forsythe LK, Wallace JM, Livingstone MB. Obesity and inflammation: The effects of weight loss. Nutr Res Rev 2008; 21: 117-133
34. Matsuzawa Y. Adiponectin: A key player in obesity related disorders. Curr Pharm Des 2010; 16: 1896-1901
35. Schneider JG, von Eynatten M, Schiekofer S, Nawroth PP, Dugi KA. Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. Diabetes Care 2005; 28: 2181-2186
36. Benoit SC, Clegg DJ, Seeley RJ, Woods SC. Insulin and leptin as adiposity signals. Recent Progr Horm Res 2004; 59: 267-285